Biodefense in the FY26 NDAA

The FY26 NDAA includes at least 24 provisions affecting US biodefense, featuring a mix of strategic advancements and institutional losses. Key positive developments include prohibitions on contracting with adversary-owned biotechnology providers to protect multiomic data, the establishment of a DoD Biotechnology Management Office, and the creation of a wastewater surveillance pilot program. Conversely, the act codifies the dissolution of the National Counterproliferation and Biosecurity Center (NCBC) and maintains restrictions on the National Nuclear Security Administration's (NNSA) ability to run an enduring bioassurance program. The document also highlights efforts to enhance intelligence sharing on biotechnological threats and the authorization of $137,686,000 for the Biological Threat Reduction Program.

• The FY26 NDAA prohibits federal agencies from procuring biotechnology equipment or services from companies owned or controlled by foreign adversaries that pose national security risks, specifically regarding the collection and provision of multiomic data. This measure aims to prevent genetic surveillance of the US public and military and stop the monopolization of critical biotechnologies.
• The act mandates the termination of the National Counterproliferation and Biosecurity Center (NCBC), which was responsible for coordinating intelligence on biosecurity and foreign biological threats. The Council on Strategic Risks views this as a critical loss for the intelligence community's ability to provide warnings on emerging biological threats.
• The Department of Energy is prohibited from establishing an enduring bioassurance program within the NNSA unless it is funded by a non-DoE entity. This restriction is noted as a concern because it may limit the NNSA labs' ability to routinely innovate and prepare for national biological emergencies.
• The Department of Defense is tasked with several biotechnology advancements, including the creation of a Biotechnology Management Office to coordinate with industry and academia, a bioindustrial commercialization program to expand domestic capacity, and a two-year wastewater surveillance pilot program at a minimum of four military installations.
• The NDAA authorizes $137,686,000 for the Biological Threat Reduction Program under the Cooperative Threat Reduction (CTR) program and prohibits the Secretary of Defense from discontinuing activities intended to reduce the threat of highly pathogenic disease.
• The intelligence community is directed to enhance its biotechnology capabilities through the designation of senior biotechnology officials across agencies (including CIA, NSA, and FBI), the development of a plan to streamline the sharing of intelligence on adversary biotechnological threats, and the production of a National Intelligence Estimate on PRC advancements in biotechnology.
• The Government Accountability Office (GAO) is directed to review previous US research regarding the use of ticks as delivery mechanisms for biological weapons to address persistent conspiracy theories about the origins of Lyme disease.

APA

The Council on Strategic Risks (2025). Biodefense in the FY26 NDAA. https://councilonstrategicrisks.org/2025/12/19/biodefense-in-the-fy26-ndaa/

Chicago

The Council on Strategic Risks. Biodefense in the FY26 NDAA. 2025. https://councilonstrategicrisks.org/2025/12/19/biodefense-in-the-fy26-ndaa/.

Wikipedia

{{cite report |author=The Council on Strategic Risks |title=Biodefense in the FY26 NDAA |date=19 December 2025 |url=https://councilonstrategicrisks.org/2025/12/19/biodefense-in-the-fy26-ndaa/ |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@techreport{thecouncilonstrategicrisks2025biodefense, author = {{The Council on Strategic Risks}}, title = {{Biodefense in the FY26 NDAA}}, institution = {The Council on Strategic Risks}, year = {2025}, month = dec, url = {https://councilonstrategicrisks.org/2025/12/19/biodefense-in-the-fy26-ndaa/}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }